Back to Search
Start Over
Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura. Reply.
- Source :
-
The New England journal of medicine [N Engl J Med] 2024 Jul 25; Vol. 391 (4), pp. 383-384. - Publication Year :
- 2024
- Subjects :
- Humans
ADAM Proteins therapeutic use
Recombinant Proteins therapeutic use
Bortezomib therapeutic use
Immunoglobulins, Intravenous therapeutic use
ADAMTS13 Protein deficiency
ADAMTS13 Protein therapeutic use
Purpura, Thrombotic Thrombocytopenic drug therapy
Purpura, Thrombotic Thrombocytopenic therapy
Hematologic Agents therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1533-4406
- Volume :
- 391
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- The New England journal of medicine
- Publication Type :
- Editorial & Opinion
- Accession number :
- 39047257
- Full Text :
- https://doi.org/10.1056/NEJMc2406975